Low-Dose Radiation Therapy with Nivolumab in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of the Phase II Radvax Trial

Category Primary study
JournalBLOOD
Year 2022
This article has no abstract
Epistemonikos ID: 5f7501160d6394a9b4a8ee044b756398eba13a27
First added on: Apr 24, 2024